Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 4/20 | 0.37 |
| ▸ | CES1 | P23141 | 4/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESRRG | P62508 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8412560 | 0.81 | CES2 (0.57) | CES2CES1ESR1 | |
| SCHEMBL39274 | 0.81 | CES2 (0.55) | ESR2CES2CES1ESR1 | |
| SCHEMBL16795568 | 0.69 | MAOA (0.45) | ESR2L3MBTL1TDP1LMNAMAPT | |
| SCHEMBL95198 | 0.69 | TDP1 (0.79) | L3MBTL1TDP1LMNAMAPTCES1 | |
| SCHEMBL17296071 | 0.69 | CES1 (0.48) | L3MBTL1MAPTCES2CES1HDAC8 | |
| SCHEMBL96371 | 0.68 | TDP1 (0.83) | L3MBTL1TDP1LMNAMAPTCES1 | |
| SCHEMBL13316192 | 0.68 | L3MBTL1 (0.47) | ESR2L3MBTL1TDP1LMNAMAPT | |
| SCHEMBL98294 | 0.68 | TDP1 (0.83) | L3MBTL1TDP1LMNAMAPTCES1 | |
| SCHEMBL8214391 | 0.68 | TDP1 (0.83) | L3MBTL1TDP1LMNAMAPTCES1 | |
| Phenol SCHEMBL8333389 | 0.67 | CA2 (0.65) | ESR2TDP1LMNAMAPTCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110392568-A | Preparation of N-acetylcystein and application thereof | 耳科制药公司 | 2019-10-29 | — | — | CN | disclosed |
| CN-110248650-A | METHODS FOR ENHANCING SYNAPTOGENESIS AND NEURITOGENESIS | 霍夫耳科研究所 | 2019-09-17 | — | — | CN | disclosed |
| EP-1922075-A2 | ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC GLIOMAS | Oklahoma Medical Research Foundation (US) | 2008-05-21 | — | — | EP | disclosed |
| WO-2007019065-A2 | ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC GLIOMAS | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20070032453-A1 | ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC GLIOMAS | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 2007-02-08 | — | — | US | disclosed |
| US-20050272724-A1 | Spin trapping pharmaceutical compositions and methods for use thereof | CARNEY JOHN M | 2005-12-08 | — | — | US | disclosed |
| US-20050107366-A1 | Spin trapping pharmaceutical compositions and methods for use thereof | CARNEY JOHN M (US) | 2005-05-19 | — | — | US | disclosed |
| US-6403627-B1 | FOR TREATMENT OF DYSFUNCTIONS AND DISEASE CONDITIONS ARISING FROM OXIDATIVE DAMAGE; PHENYL N-TERT-BUTYLNITRONE DERIVATIVES | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 2002-06-11 | — | — | US | disclosed |
| EP-0590072-B1 | USE OF SPIN TRAPPING FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OXIDATION OF LIPIDS AND PROTEINS | OKLAHOMA MED RES FOUND (US) | 2001-12-05 | — | — | EP | disclosed |
| EP-0949915-A4 | NITRONE FREE RADICAL TRAP TREATMENT OF DEMENTIA ASSOCIATED WITH AIDS VIRUS (HIV-1) INFECTION | OKLAHOMA MED RES FOUND (US) | 2001-07-04 | — | — | EP | disclosed |
| EP-0496796-B1 | METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE | OKLAHOMA MED RES FOUND (US) | 1994-08-31 | — | — | EP | disclosed |
| EP-0590072-A1 | USE OF SPIN TRAPPING FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OXIDATION OF LIPIDS AND PROTEINS | Oklahoma Medical Research Foundation (US) | 1994-04-06 | — | — | EP | disclosed |
| EP-0518951-A4 | PHENYL BUTYL NITRONE COMPOSITIONS FOR PREVENTION OF GASTRIC ULCERATION | — | 1993-02-24 | — | — | EP | disclosed |
| EP-0518951-A1 | PHENYL BUTYL NITRONE COMPOSITIONS FOR PREVENTION OF GASTRIC ULCERATION | Oklahoma Medical Research Foundation (US) | 1992-12-23 | — | — | EP | disclosed |
| WO-1992022290-A1 | USE OF SPIN TRAPPING FOR THE TREATMENT OF DISEASES ASSOCIATED WITH OXIDATION OF LIPIDS AND PROTEINS | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1992-12-23 | — | — | WO | disclosed |
| EP-0496796-A1 | METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE. | OKLAHOMA MED RES FOUND (US) | 1992-08-05 | — | — | EP | disclosed |
| WO-1991013618-A1 | PHENYL BUTYL NITRONE COMPOSITIONS FOR PREVENTION OF GASTRIC ULCERATION | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1991-09-19 | — | — | WO | disclosed |
| US-5036097-A | Antiinflammatory agents/non-steriodal | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1991-07-30 | — | — | US | disclosed |
| US-5025032-A | For ischemia or inflammation of brain or nervous system | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1991-06-18 | — | — | US | disclosed |
| WO-1991005552-A1 | METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1991-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272724-A1 | Spin trapping pharmaceutical compositions and methods for use thereof | PPOX, TXN2, TXN | ESR2 2442/4885L3MBTL1 2804/4885TDP1 279/4885 |
| US-20050107366-A1 | Spin trapping pharmaceutical compositions and methods for use thereof | PPOX, TXN2, TXN | ESR2 2442/4885L3MBTL1 2804/4885TDP1 279/4885 |
| US-20070032453-A1 | ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC GLIOMAS | MGMT, NOS3, NNMT | ESR2 2169/4885L3MBTL1 3793/4885TDP1 1105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.